BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37231196)

  • 1. Senescence-induced immune remodeling facilitates metastatic adrenal cancer in a sex-dimorphic manner.
    Warde KM; Smith LJ; Liu L; Stubben CJ; Lohman BK; Willett PW; Ammer JL; Castaneda-Hernandez G; Imodoye SO; Zhang C; Jones KD; Converso-Baran K; Ekiz HA; Barry M; Clay MR; Kiseljak-Vassiliades K; Giordano TJ; Hammer GD; Basham KJ
    Nat Aging; 2023 Jul; 3(7):846-865. PubMed ID: 37231196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexually dimorphic activation of innate antitumor immunity prevents adrenocortical carcinoma development.
    Wilmouth JJ; Olabe J; Garcia-Garcia D; Lucas C; Guiton R; Roucher-Boulez F; Dufour D; Damon-Soubeyrand C; Sahut-Barnola I; Pointud JC; Renaud Y; Levasseur A; Tauveron I; Lefrançois-Martinez AM; Martinez A; Val P
    Sci Adv; 2022 Oct; 8(41):eadd0422. PubMed ID: 36240276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular Senescence in Adrenocortical Biology and Its Disorders.
    Gao X; Li F; Liu B; Wang Y; Wang Y; Zhou H
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related Changes in the Adrenal Cortex: Insights and Implications.
    Warde KM; Smith LJ; Basham KJ
    J Endocr Soc; 2023 Aug; 7(9):bvad097. PubMed ID: 37564884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplatform computational analysis of mast cells in adrenocortical carcinoma tumor microenvironment.
    Baechle JJ; Hanna DN; Sekhar KR; Rathmell JC; Rathmell WK; Baregamian N
    Surgery; 2022 Jan; 171(1):111-118. PubMed ID: 34261605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
    Brown TC; Nicolson NG; Korah R; Carling T
    J Am Coll Surg; 2018 Jun; 226(6):988-995. PubMed ID: 29428231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an immune-related gene signature as a prognostic target and the immune microenvironment for adrenocortical carcinoma.
    Xu C; Qin C; Jian J; Peng Y; Wang X; Chen X; Wu D; Song Y
    Immun Inflamm Dis; 2022 Sep; 10(9):e680. PubMed ID: 36039643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenocortical Carcinoma Steroid Profiles:
    Muzzi JCD; Magno JM; Cardoso MA; de Moura J; Castro MAA; Figueiredo BC
    Front Endocrinol (Lausanne); 2021; 12():672319. PubMed ID: 34194394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in understanding the molecular underpinnings of adrenocortical tumors.
    Nicolson NG; Man J; Carling T
    Curr Opin Oncol; 2018 Jan; 30(1):16-22. PubMed ID: 29028646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape.
    Fojo T; Huff L; Litman T; Im K; Edgerly M; Del Rivero J; Pittaluga S; Merino M; Bates SE; Dean M
    BMC Med Genomics; 2020 Nov; 13(1):165. PubMed ID: 33148256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.
    Juhlin CC; Goh G; Healy JM; Fonseca AL; Scholl UI; Stenman A; Kunstman JW; Brown TC; Overton JD; Mane SM; Nelson-Williams C; Bäckdahl M; Suttorp AC; Haase M; Choi M; Schlessinger J; Rimm DL; Höög A; Prasad ML; Korah R; Larsson C; Lifton RP; Carling T
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E493-502. PubMed ID: 25490274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
    Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
    Front Immunol; 2021; 12():637933. PubMed ID: 33746977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonic hedgehog signaling is active in human adrenal cortex development and deregulated in adrenocortical tumors.
    Gomes DC; Leal LF; Mermejo LM; Scrideli CA; Martinelli CE; Fragoso MC; Latronico AC; Tone LG; Tucci S; Yunes JA; Cardinalli IA; Mastellaro MJ; Brandalise SR; Ramalho F; Moreira AC; Ramalho LN; de Castro M; Antonini SR
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1209-16. PubMed ID: 24712566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
    Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
    BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence.
    Wang D; Xiao F; Feng Z; Li M; Kong L; Huang L; Wei Y; Li H; Liu F; Zhang H; Zhang W
    Breast Cancer Res; 2020 Sep; 22(1):103. PubMed ID: 32993785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of a tumor mutation burden-related signature combined with immune microenvironment infiltration in adrenocortical carcinoma.
    Luo Y; Chen Q; Lin J
    Math Biosci Eng; 2022 May; 19(7):7055-7075. PubMed ID: 35730296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial predisposition to adrenocortical tumors: clinical and biological features and management strategies.
    Ribeiro RC; Pinto EM; Zambetti GP
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):477-90. PubMed ID: 20833338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetics of adrenocortical tumors.
    Espiard S; Bertherat J
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):311-34. PubMed ID: 26038203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.